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Several viral infections, including human immunodefi-
ciency virus, hepatitis B and C viruses, and cytomegalovi-
rus can be transferred from mothers to their infants; these
viruses may establish persistent infections and are a signif-
icant source of child morbidity and mortality globally.
The development of successful preventive antiviral or vac-
cine strategies is dependent upon better understanding of
the infection process and transmitted viral strains, along
with defining immune correlates of protection against
infection or natural disease. Unique features of MTCT
may be particularly helpful in understanding correlates of
immune protection. Neonatal vaccination may not only
prevent mother-to-child transmission but may also pro-
vide lifetime immunity. It is thus also important to define
how best to elicit durable protective immune responses in
infants.
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